CD274 and non-small cell lung carcinoma: Non-small-cell lung cancer patients with a mutated KMT2C gene have a higher TMB as well as PD-L1+/TMB-H, which are associated with a significantly longer median progression-free survival than those with wild-type KMT2C [38].